Intuitive Surgical Inc (ISRG)
398.82
+2.39
(+0.60%)
USD |
NASDAQ |
May 17, 16:00
398.59
-0.23
(-0.06%)
After-Hours: 20:00
Intuitive Surgical SG&A Expense (Quarterly): 491.50M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 491.50M |
December 31, 2023 | 567.10M |
September 30, 2023 | 452.00M |
June 30, 2023 | 464.30M |
March 31, 2023 | 480.50M |
December 31, 2022 | 494.30M |
September 30, 2022 | 436.10M |
June 30, 2022 | 418.40M |
March 31, 2022 | 391.10M |
December 31, 2021 | 427.00M |
September 30, 2021 | 363.30M |
June 30, 2021 | 350.20M |
March 31, 2021 | 326.00M |
December 31, 2020 | 330.20M |
September 30, 2020 | 298.90M |
June 30, 2020 | 279.10M |
March 31, 2020 | 308.10M |
December 31, 2019 | 341.80M |
September 30, 2019 | 284.00M |
June 30, 2019 | 279.20M |
March 31, 2019 | 273.40M |
December 31, 2018 | 283.80M |
September 30, 2018 | 221.40M |
June 30, 2018 | 259.80M |
March 31, 2018 | 221.60M |
Date | Value |
---|---|
December 31, 2017 | 217.90M |
September 30, 2017 | 204.10M |
June 30, 2017 | 185.60M |
March 31, 2017 | 202.90M |
December 31, 2016 | 192.00M |
September 30, 2016 | 168.00M |
June 30, 2016 | 170.80M |
March 31, 2016 | 172.80M |
December 31, 2015 | 160.30M |
September 30, 2015 | 154.90M |
June 30, 2015 | 163.30M |
March 31, 2015 | 162.00M |
December 31, 2014 | 160.00M |
September 30, 2014 | 154.00M |
June 30, 2014 | 161.20M |
March 31, 2014 | 215.80M |
December 31, 2013 | 147.70M |
September 30, 2013 | 139.30M |
June 30, 2013 | 145.50M |
March 31, 2013 | 141.50M |
December 31, 2012 | 148.10M |
September 30, 2012 | 129.00M |
June 30, 2012 | 120.90M |
March 31, 2012 | 124.20M |
December 31, 2011 | 122.00M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
279.10M
Minimum
Jun 2020
567.10M
Maximum
Dec 2023
389.16M
Average
377.20M
Median
SG&A Expense (Quarterly) Benchmarks
Abbott Laboratories | 2.959B |
Becton Dickinson & Co | 1.193B |
PROCEPT BioRobotics Corp | 39.60M |
Alphatec Holdings Inc | 113.73M |
Masimo Corp | 159.90M |